Alnylam Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2015
Total Assets: $1.39B
Liabilities Breakdown FY2015
Total Liabilities: $121.8M
Asset Breakdown
Total Assets: $1.39B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $180.9M | 13.0% |
| Accounts Receivable | $8.3M | 0.6% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $27.8M | 2.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.17B | 84.3% |
Liabilities Breakdown
Total Liabilities: $121.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $16.8M | 13.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $105.0M | 86.2% |